The Global Market for Syringes is Projected to Exceed US$20.9 Billion by 2024

Rising Healthcare Needs & Increasing Focus on Healthcare Safety and Infection Control Continue to Drive Demand for Syringes, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Syringes (Disposable & Reusable) market. The global market for Syringes is projected to exceed US$20.9 billion by 2024, driven by growing healthcare burden compounded by aging population and rise of chronic and infectious diseases, and the ensuing increase in interventional care involving surgeries and needle stick procedures.  

Syringes are widely used in hospitals, in immunization programs, in intravenous drug usage and in daily insulin by people with diabetes. Development of new drugs and demographic factors such as an aging population requiring intensive healthcare continues to drive the demand for syringes. Other factors driving growth include increasing prevalence of chronic and infectious diseases that require intravenous administration of drugs, increasing use of biological drugs, and government regulations focused on patient and healthcare worker safety. Demand for safety syringes continues to expand amidst growing emphasis on safety to avoid risk of cross-contamination and transmission of bloodborne pathogens. The need for pain-free administration of injections, and regulations dictating practices in healthcare work environment among others contribute to the development of safety syringes. Another factor driving demand is the difficulty encountered in the disposal of conventional needle syringes. A large and growing number of insulin dependent diabetics propel the insulin syringe market.

Design and recommendations for safety syringes have evolved over the years beginning with AD syringes for immunization programs and advancing to syringes with re-use prevention design and sharps injury protection features.   Other advancements include introduction of metal-free syringes. Ongoing research in the pain free syringes space is to allow injections without pain, with smaller needles. Hypodermic syringes represent the largest product market. Demand for prefilled syringes for self-administration is on the rise supported by  increased use of biologic and injectable drugs, growing elderly population, rise in self-administered injections, and increasing incidences of chronic diseases that require accurate and high dosing. Due to the growing use of self-injection systems, which are combination products, human factors are playing a major role in the design of self-injection systems, so as to limit any risk of user mishandling.

As stated by the new market research report on Syringes (Disposable & Reusable), the United States represents the largest market worldwide. Asia-Pacific is forecast to witness the fastest growth with a CAGR of 9.0% over the analysis period driven by factors such as growing focus on patient-oriented care, expansion of healthcare services in public as well as private sectors, and active adoption of various national-level disease control projects.

Major players in the market include Abbott Laboratories Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, Kawamoto Corporation, Medline Industries Inc., Merit Medical Systems, Nipro Medical Corporation Retractable Technologies, Smiths Medical, and Terumo Corporation among others.

The research report titled "Syringes (Disposable & Reusable): A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections for geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Middle East and Latin America (Brazil and Rest of Latin America). Product segments analyzed include Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes (Prefilled and Others), Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.